Literature DB >> 20856667

Two separate episodes of intramedullary spinal cord metastasis in a single patient with breast cancer.

Hyun Chul Choi1, Do Heum Yoon, Seung Chul Kim, Ki Hong Cho, Sang Hyun Kim.   

Abstract

Intramedullary spinal cord metastases are very rare. Patients with breast cancer as the primary source of intramedullary spinal cord metastases tend to do better than other types of cancer. We report the very unusual case of a woman with breast cancer who had two separate episodes of intramedullary spinal cord metastasis.

Entities:  

Keywords:  Breast cancer; Cervical; Intramedullary; Metastases; Surgical treatment; Thoracolumbar

Year:  2010        PMID: 20856667      PMCID: PMC2941861          DOI: 10.3340/jkns.2010.48.2.162

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  17 in total

Review 1.  Leptomeningeal metastases.

Authors:  Santosh Kesari; Tracy T Batchelor
Journal:  Neurol Clin       Date:  2003-02       Impact factor: 3.806

Review 2.  Intramedullary spinal cord metastases in breast cancer: report of four cases and review of the literature.

Authors:  Christos Kosmas; Maria Koumpou; Maria Nikolaou; John Katselis; Georgia Soukouli; Nina Markoutsaki; Vassiliki Kostopoulou; Assimina Gaglia; Nikolaos Mylonakis; Athanassios Karabelis; Dimitrios Pectasides
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

3.  Intramedullary spinal cord metastasis: report of three cases and review of the literature.

Authors:  E S Connolly; C J Winfree; P C McCormick; M Cruz; B M Stein
Journal:  Surg Neurol       Date:  1996-10

4.  Solitary intramedullary spinal cord tumor presenting as the initial manifestation of metastatic renal cell carcinoma: case report.

Authors:  Daniel J Donovan; Judy H Freeman
Journal:  Spine (Phila Pa 1976)       Date:  2006-06-15       Impact factor: 3.468

Review 5.  Intramedullary spinal cord metastases: diagnosis and treatment - an illustrated review.

Authors:  M Kalayci; F Cağavi; S Gül; S Yenidünya; B Açikgöz
Journal:  Acta Neurochir (Wien)       Date:  2004-11-08       Impact factor: 2.216

6.  Clinical features and natural history of intramedullary spinal cord metastasis.

Authors:  J L Grem; J Burgess; D L Trump
Journal:  Cancer       Date:  1985-11-01       Impact factor: 6.860

7.  Microsurgical treatment of intramedullary spinal cord tumors.

Authors:  N Hejazi; W Hassler
Journal:  Neurol Med Chir (Tokyo)       Date:  1998-05       Impact factor: 1.742

8.  Intramedullary spinal cord metastasis: a clinical and imaging study of seven patients.

Authors:  Masahiko Watanabe; Takeshi Nomura; Eiren Toh; Masato Sato; Joji Mochida
Journal:  J Spinal Disord Tech       Date:  2006-02

9.  Intramedullary spinal cord metastasis. A clinicopathological study of 13 cases.

Authors:  D A Costigan; M D Winkelman
Journal:  J Neurosurg       Date:  1985-02       Impact factor: 5.115

10.  Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma.

Authors:  S Toikkanen; L Pylkkänen; H Joensuu
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  4 in total

Review 1.  Conus medullaris metastasis in breast cancer: report of a case and a review of the literature.

Authors:  Kao-Chih Hsu; Tsung-Ying Li; Heng-Yi Chu; Liang-Cheng Chen; Shin-Tsu Chang; Yung-Tsan Wu
Journal:  Surg Today       Date:  2012-08-08       Impact factor: 2.549

2.  Current insights into surgery for intramedullary spinal cord metastases: a literature review.

Authors:  Ondrej Kalita
Journal:  Int J Surg Oncol       Date:  2011-05-26

3.  Spinal intramedullary metastasis of breast cancer.

Authors:  Recep Basaran; Mehmet Tiryaki; Dilek Yavuzer; Mustafa Efendioglu; Ece Balkuv; Aydin Sav
Journal:  Case Rep Med       Date:  2014-11-13

Review 4.  Rare sites of breast cancer metastasis: a review.

Authors:  Rosa Di Micco; Letizia Santurro; Maria Luisa Gasparri; Veronica Zuber; Enrico Fiacco; Guglielmo Gazzetta; Chanel Elisha Smart; Alice Valentini; Oreste Davide Gentilini
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.